comparemela.com

Latest Breaking News On - Mersana dolaflexin - Page 1 : comparemela.com

Mersana Therapeutics Announces Appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program LeadershipBrian DeSchuytner named SVP and Chief Financial Officer

Mersana Therapeutics Announces Appointment of Mohan Bala, Ph.D., as SVP, Strategic Product Planning & Program LeadershipBrian DeSchuytner named SVP and Chief Financial Officer - read this article along with other careers information, tips and advice on BioSpace

United kingdomSarah carmodyBrian deschuytnerMersana dolaflexinAnna protopapasMohan balaStrategic product planning program leadershipMersana therapeutics incExchange commissionCompany immunosynthenDevelopment programConstellation pharmaceuticalsUniversity of chicagoCompany quarterly report on formStrategic product planningProgram leadershipChief financialProduct strategyChief operating officerDevelopment program leadManagement scienceQuarterly reportErsana therapeutics announces appointment of mohan balaS svpTrategic product planning amp program leadershipbrian deschuytner named svp and chief financial officer

Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer

Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomMersana dolaflexinAnna protopapasMichael kaufmanContactsarah carmodyTushar misraTechnical operations at wave life sciencesNational institute of technologySepracor incMersana therapeutics incSciences at sunovion pharmaceuticals incExchange commissionTakeda pharmaceuticalsPrior to wave life sciencesUniversity of rhode islandCompany immunosynthenCompany quarterly report on formHead of technical development manufacturing at larondeWall streetChief manufacturing officerTechnical developmentTechnical operationsWave lifeWave life sciencesGlobal oncologyPharmaceutical sciencesSunovion pharmaceuticalsRhode islandNational instituteMersana therapeuticsmersana therapeuticsLooking statementsthisQuarterly reportMedia contactsarah carmodyMersana therapeuticsஒன்றுபட்டது கிஂக்டம்மைக்கேல் காஃப்மந்தேசிய நிறுவனம் ஆஃப் தொழில்நுட்பம்பரிமாற்றம் தரகுடாகேடா மருந்துகள்பல்கலைக்கழகம் ஆஃப் ரோட் தீவுநிறுவனம் காலாண்டு அறிக்கை ஆன் வடிவம்சுவர் தெருதலைமை உற்பத்தி அதிகாரிதொழில்நுட்ப வளர்ச்சிதொழில்நுட்ப செயல்பாடுகள்அலை வாழ்க்கைஅலை வாழ்க்கை அறிவியல்உலகளாவிய புற்றுநோயியல்மருந்து அறிவியல்ரோட் தீவுதேசிய நிறுவனம்காலாண்டு அறிக்கை

Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer

Mersana Therapeutics Announces Appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer April 26, 2021 08:00 ET | Source: Mersana Therapeutics, Inc. Mersana Therapeutics, Inc. Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the appointment of Alejandra Carvajal as Senior Vice President and Chief Legal Officer. “With our UPLIFT strategy now underway for UpRi and our growing pipeline of product candidates derived from our innovative ADC platforms, we are thrilled to have Alejandra join the team at this time of immense growth,” said Anna Protopapas, President and Chief Executive Officer of Mersana Therapeutics. “Alejand

United kingdomHill barlowMersana dolaflexinAnna protopapasMomenta pharmaceuticalsGeorgetown university law centerMersana therapeutics incBerry howardMillennium pharmaceuticalsHarvard universityCompany immunosynthenAlejandra carvajalSenior vice presidentChief legalChief executive officerChief legal officerGeneral counselVice presidentJuris doctorateNasdaq mrsnMersana therapeuticsஒன்றுபட்டது கிஂக்டம்மலை பார்லோஜார்ஜ்டவுன் பல்கலைக்கழகம் சட்டம் மையம்பெர்ரி ஹோவர்ட்மில்லினியம் மருந்துகள்ஹார்வர்ட் பல்கலைக்கழகம்அலெஜாண்ட்ரா கார்வாஜல்மூத்தவர் துணை ப்ரெஸிடெஂட்தலைமை சட்டப்பூர்வமானதுதலைமை நிர்வாகி அதிகாரிதலைமை சட்டப்பூர்வமானது அதிகாரிஜநரல் ஆலோசனைதுணை ப்ரெஸிடெஂட்ஜூரிஸ் முனைவர் பட்டம்

Mersana Therapeutics Announces Appointment of Allene Diaz to Board of Directors

Published: Mar 11, 2021 CAMBRIDGE, Mass., March 11, 2021 (GLOBE NEWSWIRE) Mersana Therapeutics, Inc.. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the appointment of Allene Diaz to its board of directors. “Allene’s breadth of knowledge in strategic product planning, portfolio management and commercialization of cancer therapeutics will be invaluable to Mersana as we focus on building UpRi as a foundational therapy for the treatment of ovarian cancer and building out our maturing pipeline of ADC candidates. With our growing portfolio of product candidates, the strategic choices we make to create differentiated product labeling and positioning are critical to our vision of discovering and developing life-changing ADC therapies for patients fighting cancer. We are excited to benefit from Allene’s experienc

United kingdomSarah carmodyMersana dolaflexinAnna protopapasAllene diazFlorida state universityCancervax corporationAllena pharmaceuticalsAcquisition corporationMersana therapeutics incExchange commissionCompany annual report on formMerck kgaParke davis pharmaceuticalsCompany immunosynthenMerck kgaaChief executive officerSenior vice presidentFlorida stateAnnual reportMersana therapeutics announces appointment of allene diaz to board directorsஒன்றுபட்டது கிஂக்டம்சாரா கார்மோடிஅல்லீன் டியாஸ்புளோரிடா நிலை பல்கலைக்கழகம்அலெனா மருந்துகள்கையகப்படுத்தல் நிறுவனம்பரிமாற்றம் தரகுநிறுவனம் ஆண்டு அறிக்கை ஆன் வடிவம்மெர்க் க்கபார்க் டேவிஸ் மருந்துகள்தலைமை நிர்வாகி அதிகாரிமூத்தவர் துணை ப்ரெஸிடெஂட்புளோரிடா நிலைஆண்டு அறிக்கை

vimarsana © 2020. All Rights Reserved.